KV Inks Licensing Deal With Spanish Pharmaceutical Firm

KV Pharmaceutical Co. will license two of its women's health products to ISDIN, S.A. in Spain, Portugal and Andorra, it said Thursday. Under the deal, KV will receive liscensing fees and manufacturing revenue for its Gynazole-1 and Clindesse products. Gynazole-1 is expected to be introduced in Spain next March, with Clindesse following.

St. Louis Business Journal (http://www.bizjournals.com/stlouis/stories/2005/03/28/daily49.html)